• Yeon Ho You, Yong Nam In, Jung Soo Park, Insool Yoo, Seung Whan Kim, Jinwoong Lee, Seung Ryu, Jin Hong Min, Won Joon Jeong, Yong Chul Cho, Se Kwang Oh, Hong Joon Ahn, Chang Shin Kang, Byung Kook Lee, Dong Hun Lee, Dong Hoon Lee, and Gyeong Gyu Yu.
• Department of Emergency Medicine, Chungnam National University Hospital.
• Medicine (Baltimore). 2021 Jun 18; 100 (24): e26260e26260.

AbstractThis study aimed to evaluate times for measuring serum lactate dehydrogenase levels (SLLs) to predict neurological prognosis among out-of-hospital cardiac arrest (OHCA) survivors.This retrospective study examined patients who experienced OHCA treated with targeted temperature management (TTM). The SLLs were evaluated at the return of spontaneous circulation (ROSC) and at 24, 48, and 72 hours later. Neurological outcomes after 3 months were evaluated for relationships with the SLL measurement times.A total of 95 comatose patients with OHCA were treated using TTM. Seventy three patients were considered eligible, including 31 patients (42%) who experienced good neurological outcomes. There were significant differences between the good and poor outcome groups at most time points (P < .001), except for ROSC (P = .06). The ROSC measurement had a lower area under the receiver operating characteristic curve (AUC: 0.631, 95% confidence interval [CI]: 0.502-0.761) than at 48 hours (AUC: 0.830, 95% CI: 0.736-0.924), at 24 hours (AUC: 0.786, 95% CI: 0.681-0.892), and at 72 hours (AUC: 0.821, 95% CI: 0.724-0.919).A higher SLL seemingly predicted poor neurological outcomes, with good prognostic values at 48 hours and 72 hours. Prospective studies should be conducted to confirm these results.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

24 keywords...

hide…